Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect

BACKGROUND: The vast majority of patients with cholangiocarcinoma (CC) have advanced disease at diagnosis and are candidates for palliative treatment only. The robustness of the randomized controlled trials regarding the treatment of CC are assessed. METHODS: A systematic review of all randomized co...

Descripción completa

Detalles Bibliográficos
Autores principales: Horesh, Nir, Bomze, David, Lim, Chetana, Markel, Gal, Meirson, Tomer, Azoulay, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745612/
https://www.ncbi.nlm.nih.gov/pubmed/36523938
http://dx.doi.org/10.21037/hbsn-21-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745612/
https://www.ncbi.nlm.nih.gov/pubmed/36523938
http://dx.doi.org/10.21037/hbsn-21-118

Ejemplares similares